The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia

Behavioral and Brain Functions

Volumn 9, Issue 1, 2013, Pages

  Ohi, Kazutaka ^a,b,c   Hashimoto, Ryota ^a,c,d   Yamamori, Hidenaga ^a,c   Yasuda, Yuka ^a,c   Fujimoto, Michiko ^a,c   Umeda Yano, Satomi ^a   Fukunaga, Masaki ^d   Watanabe, Yoshiyuki ^a   Iwase, Masao ^a   Kazui, Hiroaki ^a   Takeda, Masatoshi ^a,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yamato Mental Medical Center   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Cyclin M2 (CNNM2); Genome wide association study; Inferior frontal gyrus; Schizophrenia; Voxel based morphometry

Indexed keywords

CYCLIN M2; CYCLINE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HAPLOTYPE MAP; HARDY WEINBERG EQUILIBRIUM TESTING; HOMOZYGOTE; HUMAN; INFERIOR FRONTAL GYRUS; JAPANESE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VOXEL BASED MORPHOMETRY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLINS; FEMALE; FRONTAL LOBE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84886153297     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-9-40     Document Type: Article

References (49)

1. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192. 10.1001/archpsyc.60.12.1187, 14662550.
2. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1173-1181. 10.1002/ajmg.b.30743, 18361404.
3. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747. 3077530, 19571808.
4. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Moller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055. 10.1038/ng.201, 18677311.
5. Rose EJ, Donohoe G. Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophr Bull 2013, 39:518-526. 10.1093/schbul/sbs056, 22499782.
6. Ohi K, Hashimoto R, Yasuda Y, Nemoto K, Ohnishi T, Fukumoto M, Yamamori H, Umeda-Yano S, Okada T, Iwase M, Kazui H, Takeda M. Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia. PLoS One 2012, 7:e29780. 10.1371/journal.pone.0029780, 3257237, 22253779.
7. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA, Lin DY, Duan J, Ophoff RA, Andreassen OA, Scolnick E, Cichon S, St Clair D, Corvin A, Gurling H, Werge T, Rujescu D, Blackwood DH, Pato CN, Malhotra AK, Purcell S, Dudbridge F, Neale BM, Rossin L, Visscher PM, Posthuma D, Ruderfer DM, Fanous A, Stefansson H, Steinberg S, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011, 43:969-976. 10.1038/ng.940, 3303194, 21926974.
8. Whalley HC, Papmeyer M, Romaniuk L, Sprooten E, Johnstone EC, Hall J, Lawrie SM, Evans KL, Blumberg HP, Sussmann JE, McIntosh AM. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology 2012, 37:2720-2729. 10.1038/npp.2012.137, 22850735.
9. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7:818-827. 10.1038/nrn1993, 16988657.
10. Tan HY, Callicott JH, Weinberger DR. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer?. Mol Psychiatry 2008, 13:233-238. 10.1038/sj.mp.4002145, 18285755.
11. Potkin SG, Turner JA, Guffanti G, Lakatos A, Torri F, Keator DB, Macciardi F. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn Neuropsychiatry 2009, 14:391-418. 10.1080/13546800903059829, 3037334, 19634037.
12. Kaymaz N, van Os J. Heritability of structural brain traits an endophenotype approach to deconstruct schizophrenia. Int Rev Neurobiol 2009, 89:85-130.
13. Rijsdijsk FV, Viding E, De Brito S, Forgiarini M, Mechelli A, Jones AP, McCrory E. Heritable variations in gray matter concentration as a potential endophenotype for psychopathic traits. Arch Gen Psychiatry 2010, 67:406-413. 10.1001/archgenpsychiatry.2010.20, 20368516.
14. Chan RC, Di X, McAlonan GM, Gong QY. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull 2011, 37:177-188. 10.1093/schbul/sbp073, 3004195, 19633214.
15. Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, Chua S, McAlonan G. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 2011, 37:199-211. 10.1093/schbul/sbp099, 3004197, 19759093.
16. Ren W, Lui S, Deng W, Li F, Li M, Huang X, Wang Y, Li T, Sweeney JA, Gong Q. Anatomical and functional brain abnormalities in drug-naive first-episode schizophrenia. Am J Psychiatry in press.
17. Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, Weinberger DR, Meyer-Lindenberg A. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry 2009, 66:467-477. 10.1001/archgenpsychiatry.2009.24, 2719488, 19414706.
18. Meyer-Lindenberg A. Imaging genetics of schizophrenia. Dialogues Clin Neurosci 2010, 12:449-456. 3181991, 21319490.
19. Hashimoto R, Hashimoto H, Shintani N, Chiba S, Hattori S, Okada T, Nakajima M, Tanaka K, Kawagishi N, Nemoto K, Mori T, Ohnishi T, Noguchi H, Hori H, Suzuki T, Iwata N, Ozaki N, Nakabayashi T, Saitoh O, Kosuga A, Tatsumi M, Kamijima K, Weinberger DR, Kunugi H, Baba A. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 2007, 12:1026-1032. 10.1038/sj.mp.4001982, 17387318.
20. Hashimoto R, Hirata Y, Asada T, Yamashita F, Nemoto K, Mori T, Moriguchi Y, Kunugi H, Arima K, Ohnishi T. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav 2009, 8:43-52. 10.1111/j.1601-183X.2008.00440.x, 18786162.
21. Hashimoto R, Moriguchi Y, Yamashita F, Mori T, Nemoto K, Okada T, Hori H, Noguchi H, Kunugi H, Ohnishi T. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res 2008, 61:360-367. 10.1016/j.neures.2008.04.003, 18501457.
22. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, Mori T, Nemoto K, Adachi N, Izumi A, Chiba S, Noguchi H, Suzuki T, Iwata N, Ozaki N, Taguchi T, Kamiya A, Kosuga A, Tatsumi M, Kamijima K, Weinberger DR, Sawa A, Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 2006, 15:3024-3033. 10.1093/hmg/ddl244, 16959794.
23. Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Nemoto K, Ohnishi T, Yamamori H, Takahashi H, Iike N, Kamino K, Yoshida T, Azechi M, Ikezawa K, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Iwase M, Kazui H, Takeda M. The AKT1 gene is associated with attention and brain morphology in schizophrenia. World J Biol Psychiatry 2013, 14:100-113. 10.3109/15622975.2011.591826, 22150081.
24. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006, 129:399-410.
25. Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Iwase M, Iike N, Azechi M, Ikezawa K, Takaya M, Takahashi H, Yamamori H, Okochi T, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Kazui H, Iwata N, Takeda M. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1459-1464. 10.1002/ajmg.b.31123, 20957649.
26. Ohi K, Hashimoto R, Yasuda Y, Kiribayashi M, Iike N, Yoshida T, Azechi M, Ikezawa K, Takahashi H, Morihara T, Ishii R, Tagami S, Iwase M, Okochi M, Kamino K, Kazui H, Tanaka T, Kudo T, Takeda M. TATA box-binding protein gene is associated with risk for schizophrenia, age at onset and prefrontal function. Genes Brain Behav 2009, 8:473-480. 10.1111/j.1601-183X.2009.00497.x, 19566714.
27. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. A new five factor model of schizophrenia. Psychiatr Q 1994, 65:299-322. 10.1007/BF02354306, 7831416.
28. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213. 10.1038/ng1706, 16415888.
29. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191. 10.3758/BF03193146, 17695343.
30. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 2010, 117:1-12. 10.1016/j.schres.2009.12.022, 20071149.
31. Wang CY, Shi JD, Yang P, Kumar PG, Li QZ, Run QG, Su YC, Scott HS, Kao KJ, She JX. Molecular cloning and characterization of a novel gene family of four ancient conserved domain proteins (ACDP). Gene 2003, 306:37-44.
32. Goytain A, Quamme GA. Functional characterization of ACDP2 (ancient conserved domain protein), a divalent metal transporter. Physiol Genomics 2005, 22:382-389. 10.1152/physiolgenomics.00058.2005, 15899945.
33. Stuiver M, Lainez S, Will C, Terryn S, Gunzel D, Debaix H, Sommer K, Kopplin K, Thumfart J, Kampik NB, Querfeld U, Willnow TE, Nemec V, Wagner CA, Hoenderop JG, Devuyst O, Knoers NV, Bindels RJ, Meij IC, Muller D. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet 2011, 88:333-343. 10.1016/j.ajhg.2011.02.005, 3059432, 21397062.
34. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, Montgomery S, Tavare S, Deloukas P, Dermitzakis ET. Population genomics of human gene expression. Nat Genet 2007, 39:1217-1224. 10.1038/ng2142, 2683249, 17873874.
35. Kochlamazashvili G, Bukalo O, Senkov O, Salmen B, Gerardy-Schahn R, Engel AK, Schachner M, Dityatev A. Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors. J Neurosci 2012, 32:2263-2275. 10.1523/JNEUROSCI.5103-11.2012, 22396402.
36. Liakakis G, Nickel J, Seitz RJ. Diversity of the inferior frontal gyrus-a meta-analysis of neuroimaging studies. Behav Brain Res 2011, 225:341-347. 10.1016/j.bbr.2011.06.022, 21729721.
37. Ross CA, Pearlson GD. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci 1996, 19:171-176. 10.1016/S0166-2236(96)10022-9, 8723199.
38. Buchanan RW, Vladar K, Barta PE, Pearlson GD. Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 1998, 155:1049-1055.
39. Yamasue H, Iwanami A, Hirayasu Y, Yamada H, Abe O, Kuroki N, Fukuda R, Tsujii K, Aoki S, Ohtomo K, Kato N, Kasai K. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res 2004, 131:195-207. 10.1016/j.pscychresns.2004.05.004, 15465289.
40. Suzuki M, Nohara S, Hagino H, Kurokawa K, Yotsutsuji T, Kawasaki Y, Takahashi T, Matsui M, Watanabe N, Seto H, Kurachi M. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res 2002, 55:41-54. 10.1016/S0920-9964(01)00224-9, 11955962.
41. Rogers RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ, Robbins TW. Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 1999, 19:9029-9038.
42. Amunts K, Schleicher A, Burgel U, Mohlberg H, Uylings HB, Zilles K. Broca's region revisited: cytoarchitecture and intersubject variability. J Comp Neurol 1999, 412:319-341. 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7, 10441759.
43. Sakai KL, Nauchi A, Tatsuno Y, Hirano K, Muraishi Y, Kimura M, Bostwick M, Yusa N. Distinct roles of left inferior frontal regions that explain individual differences in second language acquisition. Hum Brain Mapp 2009, 30:2440-2452. 10.1002/hbm.20681, 19003956.
44. Sakai KL. Language acquisition and brain development. Science 2005, 310:815-819. 10.1126/science.1113530, 16272114.
45. Bragado-Jimenez MD, Taylor PJ. Empathy, schizophrenia and violence: a systematic review. Schizophr Res 2012, 141:83-90. 10.1016/j.schres.2012.07.019, 22917950.
46. Sevy S, Burdick KE, Visweswaraiah H, Abdelmessih S, Lukin M, Yechiam E, Bechara A. Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophr Res 2007, 92:74-84. 10.1016/j.schres.2007.01.005, 2039912, 17379482.
47. Billeke P, Aboitiz F. Social cognition in schizophrenia: from social stimuli processing to social engagement. Front Psychiatry 2013, 4:4. 3580762, 23444313.
48. Kuperberg GR, Kreher DA, Ditman T. What can event-related potentials tell us about language, and perhaps even thought, in schizophrenia?. Int J Psychophysiol 2010, 75:66-76. 10.1016/j.ijpsycho.2009.09.005, 3136365, 19765622.
49. Vrtunski PB, Simpson DM, Weiss KM, Davis GC. Abnormalities of fine motor control in schizophrenia. Psychiatry Res 1986, 18:275-284. 10.1016/0165-1781(86)90114-9, 3749386.